Ulonivirine（Cat No.:I043361）is a small-molecule antiviral agent designed to inhibit the activity of the HIV-1 protease, an enzyme crucial for the maturation and replication of the virus. By targeting this enzyme, ulonivirine prevents the cleavage of viral polyproteins, disrupting the production of infectious HIV particles. This leads to a reduction in viral load and helps in managing HIV infection. In preclinical studies, ulonivirine has shown effectiveness against HIV strains resistant to other protease inhibitors. Ongoing clinical trials aim to assess its safety, efficacy, and potential role in combination antiretroviral therapy.